Industria Quimica y Farmaceutica VIR S.A. Rottendorf Pharma GmbH Synthon B.V. Synthon Hispania S.L.

The medicinal product is used in the hormonal treatment of breast cancer in postmenopausal women. It helps to prevent the recurrence of the disease and may be used before surgery, after surgery, or after five years of treatment with tamoxifen, as well as in the prevention of cancer spread in patients with advanced breast cancer.

Dosage form: tablets, film-coated

ATC: L02BG04